Profile data is unavailable for this security.
About the company
Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceuticals products segment. Its geographical segments include within India and outside India. The Company has its presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It has over eight manufacturing facilities, approximately seven of which are located in India and one in the United States. The Company sells its products in the global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific and India. The Company’s wholly owned subsidiaries include Granules USA Inc, Granules Pharmaceuticals Inc, Granules Europe Limited and Granules Lifesciences Private Limited.
- Revenue in INR (TTM)45.26bn
- Net income in INR3.95bn
- Incorporated1991
- Employees3.65k
- LocationGranules India Ltd2nd Floor3rd Block, My Home Hub MadhapurHYDERABAD 500081IndiaIND
- Phone+91 4 069043500
- Fax+91 4 023115145
- Websitehttps://granulesindia.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shilpa Medicare Ltd | 11.23bn | -6.71m | 52.52bn | 1.03k | -- | -- | 49.39 | 4.68 | -0.0714 | -0.0714 | 131.44 | -- | -- | -- | -- | 10,873,050.00 | -- | 3.89 | -- | 4.92 | 64.42 | 60.22 | -0.0538 | 9.29 | -- | 1.16 | -- | 10.65 | -8.33 | 5.82 | -153.54 | -- | 14.58 | -- |
Orchid Pharma Ltd | 8.12bn | 1.25bn | 52.96bn | 838.00 | 36.64 | -- | 33.32 | 6.52 | 28.50 | 26.84 | 175.33 | -- | -- | -- | -- | 9,691,729.00 | -- | -1.07 | -- | -1.96 | 41.49 | 45.87 | 15.63 | -3.52 | -- | 4.34 | -- | -- | 19.00 | -0.6456 | 187.87 | -- | 68.72 | -- |
Blue Jet Healthcare Ltd | -100.00bn | -100.00bn | 64.35bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 5.49 | -- | -11.88 | -- | -- | -- |
F D C Ltd | 19.16bn | 2.90bn | 73.04bn | 6.37k | 25.46 | -- | 22.23 | 3.81 | 17.63 | 17.63 | 116.59 | -- | -- | -- | -- | 3,006,457.00 | -- | 11.68 | -- | 13.29 | 65.72 | 62.03 | 15.11 | 15.85 | -- | 70.61 | -- | 1.22 | 16.74 | 10.49 | -10.34 | 2.26 | 25.03 | -- |
Sun Pharma Advanced Research Co Ltd | 1.07bn | -3.63bn | 73.18bn | 407.00 | -- | -- | -- | 68.60 | -11.22 | -11.22 | 3.29 | -- | -- | -- | -- | 2,621,133.00 | -- | -59.13 | -- | -119.29 | 75.21 | 79.70 | -340.66 | -116.46 | -- | -400.34 | -- | -- | 73.98 | 25.00 | -9.43 | -- | -13.96 | -- |
Marksans Pharma Ltd | 21.03bn | 3.17bn | 75.20bn | 1.40k | 23.54 | -- | 19.43 | 3.58 | 7.05 | 7.05 | 46.71 | -- | -- | -- | -- | 15,024,090.00 | -- | 14.78 | -- | 19.58 | 51.88 | 50.16 | 15.21 | 13.01 | -- | 44.45 | -- | 5.49 | 24.23 | 15.20 | 44.29 | 51.89 | 6.61 | 58.49 |
Procter & Gamble Health Ltd | 12.37bn | 2.27bn | 78.86bn | 1.41k | 34.79 | 9.79 | 31.24 | 6.37 | 136.55 | 136.55 | 745.23 | 485.49 | 1.15 | 2.51 | 10.40 | 8,791,756.00 | 21.02 | -- | 27.67 | -- | 69.97 | -- | 18.32 | -- | 2.79 | 383.03 | 0.0132 | -- | 10.34 | -- | 19.19 | -- | -- | -- |
Strides Pharma Science Ltd | 39.53bn | -1.52bn | 81.47bn | 2.85k | -- | -- | 137.74 | 2.06 | -16.88 | -10.96 | 436.72 | -- | -- | -- | -- | 13,871,790.00 | -- | -0.9448 | -- | -1.59 | 58.90 | 49.75 | -4.37 | -2.19 | -- | 0.9061 | -- | -- | 20.13 | 5.33 | 51.93 | -- | -25.10 | -5.59 |
Wockhardt Ltd | 27.76bn | -5.01bn | 85.16bn | 2.74k | -- | -- | -- | 3.07 | -34.79 | -34.79 | 192.79 | -- | -- | -- | -- | 10,131,390.00 | -- | -4.12 | -- | -7.34 | 57.60 | 53.98 | -19.16 | -10.98 | -- | -0.1981 | -- | -- | -17.93 | -7.60 | -129.10 | -- | -7.43 | -- |
Neuland Laboratories Ltd. | 15.81bn | 3.17bn | 96.97bn | 1.57k | 30.58 | -- | 25.94 | 6.13 | 247.14 | 247.14 | 1,232.07 | -- | -- | -- | -- | 10,048,590.00 | -- | 5.69 | -- | 7.95 | 51.76 | 43.56 | 20.06 | 8.07 | -- | 28.54 | -- | 8.27 | 25.25 | 17.62 | 156.21 | 68.43 | -13.12 | -- |
Caplin Point Laboratories Ltd | 16.30bn | 4.38bn | 98.63bn | 777.00 | 22.65 | -- | 20.14 | 6.05 | 57.33 | 57.33 | 213.53 | -- | -- | -- | -- | 20,980,180.00 | -- | 21.04 | -- | 24.25 | 56.48 | 52.84 | 27.08 | 25.02 | -- | 845.56 | -- | 9.37 | 15.54 | 22.13 | 25.49 | 21.05 | 31.87 | 17.61 |
Glenmark Life Sciences Ltd | 22.83bn | 4.71bn | 101.69bn | 1.82k | 21.62 | 4.36 | 19.39 | 4.45 | 38.38 | 38.38 | 186.08 | 190.35 | 0.8224 | 1.58 | 2.90 | -- | 16.96 | 18.28 | 20.43 | 30.03 | 56.11 | 53.40 | 20.62 | 20.23 | 2.85 | 401.55 | 0.0073 | -- | 5.64 | 20.83 | 0.841 | 19.21 | 69.11 | -- |
Granules India Ltd | 45.26bn | 3.95bn | 102.61bn | 3.65k | 25.95 | -- | 17.15 | 2.27 | 16.32 | 16.32 | 186.88 | -- | -- | -- | -- | 12,400,240.00 | -- | 11.15 | -- | 16.55 | 51.94 | 49.35 | 8.73 | 12.39 | -- | 6.53 | -- | 10.08 | 19.84 | 21.67 | 25.16 | 31.26 | -1.66 | 8.45 |
Jubilant Pharmova Ltd | 66.22bn | 378.60m | 108.67bn | 1.03k | 283.20 | -- | 18.54 | 1.64 | 2.42 | 2.42 | 415.43 | -- | -- | -- | -- | 64,045,440.00 | -- | 3.95 | -- | 4.78 | 67.64 | 66.57 | 0.5133 | 6.27 | -- | 1.36 | -- | 18.52 | 2.47 | -3.63 | -114.73 | -- | 10.74 | 10.76 |
Eris Lifesciences Ltd | 18.61bn | 3.86bn | 118.32bn | 3.55k | 30.66 | -- | 21.80 | 6.36 | 28.36 | 28.36 | 136.57 | -- | -- | -- | -- | 5,245,254.00 | -- | 17.62 | -- | 20.12 | 82.02 | 80.57 | 20.36 | 27.34 | -- | 7.94 | -- | -- | 25.10 | 14.52 | -5.90 | 5.38 | 101.87 | -- |
Astrazeneca Pharma India Ltd | 11.97bn | 1.39bn | 135.88bn | 947.00 | 97.55 | -- | 87.82 | 11.35 | 55.72 | 55.72 | 478.78 | -- | -- | -- | -- | 12,640,230.00 | -- | 10.51 | -- | 18.10 | 59.93 | 58.05 | 11.64 | 9.11 | -- | 132.84 | -- | 11.82 | 24.50 | 11.89 | 61.19 | 30.82 | 6.29 | -- |
Holder | Shares | % Held |
---|---|---|
FIL Investment Management (Singapore) Ltd.as of 31 Mar 2024 | 15.31m | 6.32% |
Life Insurance Corporation of India (Investment Portfolio)as of 30 Sep 2023 | 5.58m | 2.30% |
quant Money Managers Ltd.as of 31 Mar 2024 | 5.34m | 2.20% |
The Vanguard Group, Inc.as of 05 Apr 2024 | 5.27m | 2.17% |
Dimensional Fund Advisors LPas of 04 Apr 2024 | 4.09m | 1.69% |
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 31 Mar 2024 | 3.04m | 1.25% |
Norges Bank Investment Managementas of 30 Sep 2023 | 2.79m | 1.15% |
BlackRock Fund Advisorsas of 04 Apr 2024 | 2.66m | 1.10% |
AllianceBernstein LPas of 28 Mar 2024 | 2.56m | 1.06% |
Tata Asset Management Ltd.as of 31 Mar 2024 | 1.77m | 0.73% |